The effectiveness of switching antidepressants during remission: A case series of depressed patients who experienced intolerable side effects

Journal of Affective Disorders

Volumn 69, Issue 1-3, 2002, Pages 237-240

  Posternak, Michael A ^a   Zimmerman, Mark ^b  

^a Bayside Medical Center   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Antidepressants; Depression; Side effects; Switch

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ANORGASMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; HYPERHIDROSIS; MALE; PRIORITY JOURNAL; REMISSION; SAMPLE SIZE; SEXUAL DYSFUNCTION; VERTIGO; CLINICAL TRIAL; MAJOR DEPRESSION; MIDDLE AGED;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION, INVOLUTIONAL; FEMALE; HUMAN; MALE; MIDDLE AGE; DEPRESSIVE DISORDER, MAJOR; HUMANS; MIDDLE AGED;

EID: 0036018518     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00366-9     Document Type: Article

References (6)

1. A 102-center prospective study of seizure in association with bupropion
2. Switching versus augmentation: A prospective, naturalistic comparison in depressed, treatment-resistant patients
3. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline
4. Discontinuing antidepressant treatment in major depression
5. Does intolerance or lack of response to fluoxetine predict the same will happen with sertraline?
6. Psychiatric diagnosis in clinical practice: Is comorbidity being missed?